Zura Bio Limited
ZURA
$1.99
$0.2413.71%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 50.45% | 83.45% | 66.16% | 113.60% | 9.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.60% | 129.79% | 45.30% | 89.64% | -65.32% |
| Operating Income | -53.60% | -129.79% | -45.30% | -89.64% | 65.32% |
| Income Before Tax | -54.84% | -125.15% | -60.80% | -150.33% | 69.64% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -54.84% | -125.15% | -60.80% | -150.33% | 69.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -54.84% | -125.15% | -60.80% | -150.33% | 69.64% |
| EBIT | -53.60% | -129.79% | -45.30% | -89.64% | 65.32% |
| EBITDA | -53.51% | -- | -- | -- | -- |
| EPS Basic | -0.36% | -1,102.56% | 25.41% | -48.92% | 87.09% |
| Normalized Basic EPS | -23.11% | -13.66% | 16.87% | -34.27% | 86.11% |
| EPS Diluted | -0.36% | -1,102.56% | 25.41% | -48.92% | 87.09% |
| Normalized Diluted EPS | -23.11% | -13.66% | 16.87% | -34.27% | 86.11% |
| Average Basic Shares Outstanding | 25.81% | 98.16% | 93.31% | 86.31% | 118.49% |
| Average Diluted Shares Outstanding | 25.81% | 98.16% | 93.31% | 86.31% | 118.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |